Depression Clinical Trials in Atlanta, Georgia

9 studies are recruiting for depression in Atlanta, Georgia right now. Each one is listed on ClinicalTrials.gov, the public registry the research teams themselves file with. TrialBoost is not a doctor, a research site, or a study sponsor: the research team decides who takes part.

Search these by distance from you

Studies now recruiting

1. PCORI Comparative Effectiveness Study-Esketamine (Spravato) vs. Ketamine-Equivalence Study

   The purpose of this study is to compare the relative effectiveness, acceptability, and side effects of ketamine delivered through an IV (a drip into the arm) which is not currently FDA approved for use in the treatment of treatment-resistant depression (TRD) and Esketamine (Spravato®), taken as a n…

   Stage

   Phase 3

   Ages

   18 and older

   Site

   Emory University, Atlanta, Georgia

   Locations

   8 in total

   Run by

   Yale University

   See if you can join NCT06713616 on ClinicalTrials.gov

2. A Study of a Deuterated Psilocin Analog (CYB003) in Humans With Major Depressive Disorder

   The purpose of this study is to determine the efficacy, safety and tolerability of CYB003 compared to matching placebo as adjunctive treatment in patients with MDD. For more information about the EMBRACE study, including participating study locations, and to register your interest in learning more …

   Stage

   Phase 3

   Ages

   18 to 85

   Site

   Emory University Dept of Psychiatry and Behavioral Studies, Atlanta, Georgia

   Locations

   69 in total

   Run by

   Cybin IRL Limited

   See if you can join NCT06793397 on ClinicalTrials.gov

3. E-Mindfulness Approaches for Living After Breast Cancer

   NRG-CC015 is a prospective, randomized phase III clinical trial to evaluate the efficacy of two distinct digital approaches for delivering a mindfulness-based intervention: a live, instructor-led version delivered over Zoom (MAPs LO), and an app-based, self-paced version (MAPs App). Participants wi…

   Stage

   Phase 3

   Ages

   18 to 50

   Site

   Grady Health System, Atlanta, Georgia

   Locations

   383 in total

   Run by

   NRG Oncology

   See if you can join NCT06748222 on ClinicalTrials.gov

4. A Study to Assess Change in Disease Activity and Adverse Events (AEs) With Cariprazine in the Treatment of Depressive Episodes in Pediatric Participants Participants (10 to 17 Years of Age) With Bipolar I Disorder.

   Bipolar disorder is a severe chronic mood disorder that affects up to 4% of the adult population and 1.8% of the pediatric population in the United States. The treatment of the depressive episodes of bipolar disorder in the pediatric population has not been as widely studied as the treatment of dep…

   Stage

   Phase 3

   Ages

   10 to 17

   Site

   Atlanta Center for Medical Research /ID# 226480, Atlanta, Georgia

   Locations

   81 in total

   Run by

   AbbVie

   See if you can join NCT04777357 on ClinicalTrials.gov

5. Mechanisms of Behavioral Activation (BA)

   The investigators will be comparing brain (neural) activation of depressed adolescent patients before, during and after a course of Behavioral Activation (BA) therapy using functional magnetic resonance imaging (fMRI). In particular, the project seeks to determine whether BA targets different neura…

   Stage

   Not phased

   Ages

   15 to 17

   Site

   Emory University, Atlanta, Georgia

   Locations

   3 in total

   Run by

   Emory University

   See if you can join NCT05548244 on ClinicalTrials.gov

6. Inflammation and Depression in People With HIV

   The purpose of this 10-week, double-blind, placebo-controlled study is to determine whether inflammation impacts reward and motor neural circuitry to contribute to depressive symptoms like anhedonia and psychomotor slowing in people with Human Immunodeficiency Virus (HIV) and depression. Sixty male…

   Stage

   Phase 2

   Ages

   18 to 65

   Site

   Grady Memorial Hospital, Atlanta, Georgia

   Locations

   2 in total

   Run by

   Emory University

   See if you can join NCT05849038 on ClinicalTrials.gov

7. Dopaminergic Therapy for Anhedonia - 2

   The purpose of this 8-week, double-blind, placebo-controlled, study is to explore new treatment options for people with depression who have high inflammation and anhedonia. Seventy male and female participants with depression, between 25-55 years of age, with higher levels of inflammation and anhed…

   Stage

   Phase 4

   Ages

   25 to 55

   Site

   Emory University Hospital, Atlanta, Georgia

   Run by

   Emory University

   See if you can join NCT06075771 on ClinicalTrials.gov

8. Suicidal Behavior in Patients Diagnosed With Bipolar Disorder

   The purpose of this study is to learn the environmental and psychological factors that impact suicidality in patients diagnosed with Bipolar Disorder. Additionally, the study aims to identify treatments to reduce the suicidal behavior and improve quality of life through a 6-week group-based interve…

   Stage

   Not phased

   Ages

   18 to 64

   Site

   Grady Health System, Atlanta, Georgia

   Run by

   Emory University

   See if you can join NCT02604277 on ClinicalTrials.gov

9. Brain Stimulation and Decision-making

   Decision-making is an important process that is frequently shown to be impaired in patients with depression. While a number of preclinical and clinical studies have identified key regions involved in this process, it remains unclear exactly how these regions are influencing choice behavior especial…

   Stage

   Not phased

   Ages

   18 to 50

   Site

   Emory University, Atlanta, Georgia

   Run by

   Emory University

   See if you can join NCT04099056 on ClinicalTrials.gov